At the press conference on the prevention and control of the new coronary pneumonia in Shanghai held on May 15, Zhao Dandan, deputy director of the Shanghai Municipal Health Commission, introduced that there are two key links in nucleic acid screening, one is on-site sampling, and the other is experimental room testing.
Through the efforts of all parties, in terms of sampling capacity, through potential exploration, recruitment and other forms, the reserve of sampling personnel has been continuously increased, and special training has been carried out. At present, a sampling team of about 38,000 people has been reserved. This team will not only become the It is an important force in the follow-up screening work, and has laid a solid foundation for comprehensively promoting the layout of normalized sampling points and playing their role.
In terms of laboratory testing capacity, the city's maximum single-day testing capacity has increased from 1.028 million tubes before the current round of the epidemic to more than 8.5 million tubes by adding testing institutions, adding cabin laboratories and mobile testing vehicles.
The improvement of laboratory testing capabilities can not only meet the needs of normalized testing in Shanghai, but also enable faster reporting of test results and better meet the needs of citizens for work and life.
(Reporter Kang Yuzhan)
Responsible editor: [Li Ji]